INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2010

Saffron matched donepezil in treating mild-to-moderate Alzheimer's disease over 22 weeks.

In a 22-week randomized trial involving 54 community-dwelling adults aged 55 or older with mild-to-moderate Alzheimer's disease, 30 mg daily of saffron showed similar efficacy to 10 mg daily of donepezil. Cognitive subscale and clinical dementia rating scores were the primary outcomes. Overall adverse events occurred at similar rates, although vomiting was significantly more frequent in participants receiving donepezil.

Study type
Randomized controlled trial
Who was studied
54 community-dwelling adults aged 55 or older with Alzheimer's disease
What was measured
Cognitive and dementia rating scores, adverse events

THE PAPER

A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease.

Akhondzadeh S, Shafiee Sabet M, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi SS, Yousefi MH, Alimardani R, Jamshidi A, Rezazadeh SA, Yousefi A, Zare F, Moradi A, Vossoughi A. Psychopharmacology (Berl), 2010.

PubMed 19838862 ↗DOI 10.1007/s00213-009-1706-1 ↗

Brain & moodHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.